John H. Powers

10.9k citations

136 papers · 5.7k indexed · 3 hit papers · h-index 33

Applied Microbiology and Biotechnology top 0.1%
- Antibiotic Use and Resistance 26
Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria 17
Clinical Biochemistry top 0.5%
Infectious Diseases top 2%
Critical Care and Intensive Care Medicine top 2%
Economics and Econometrics
- Health Systems, Economic Evaluations, Quality of Life 21
- Pharmaceutical Economics and Policy 12
Epidemiology
- Pneumonia and Respiratory Infections 16
- Respiratory viral infections research 14
- Influenza Virus Research Studies 10
Statistics, Probability and Uncertainty
- Meta-analysis and systematic reviews 14

Co-authors: Thomas R. Fleming Tom Chiller Brad Spellberg Eric P. Brass John E. Edwards Loren G. Miller Laurie B. Burke Donald L. Patrick
Cited by: Applied Microbiology and Biotechnology Molecular Medicine Clinical Biochemistry
Journals: Clinical Infectious Diseases (20 papers)Value in Health (9 papers)Open Forum Infectious Diseases (6 papers)
Partner nations: United States United Kingdom Mexico

In The Last Decade

John H. Powers

128 papers receiving 5.4k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by John H. Powers

Since Specialization

Citations

This map shows the geographic impact of John H. Powers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John H. Powers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John H. Powers more than expected).

Fields of papers citing papers by John H. Powers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John H. Powers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John H. Powers. The network helps show where John H. Powers may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John H. Powers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John H. Powers Line = papers co-authored together John H. Powers links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Demographics, epidemiology, mortality and difficult-to-treat resistance patterns of bacterial bloodstream infections in the global US Military Health System from 2010 to 2019: a retrospective cohort study BMJ Open ·Ahmed ʿIsa al-Daʿrhi,G. Sanfourche,John H. Powers,Sameer S. Kadri,Sarah Warner,Uzo Chukwuma,Edna Duarte-Lopes,Charlotte Lanteri,M Leigh Carson,Katarzyna Chwaleba,Don Russ,Kozminska Aleksandra,Jing Wang,Edward Parmelee,Katrin Mende	2025	0
2	Prospective cohort study of patient demographics, viral agents, seasonality, and outcomes of influenza-like illness in Mexico in the late H1N1-pandemic and post-pandemic years (2010-2014) IJID Regions ·Arturo Galindo‐Fraga,MIA BALAH,Ana A. Ortiz‐Hernández,Yulfi,Ana M. Ortega‐Villa,Alejandra Ramírez‐Venegas,Soung Yong Jin,Sarbelio Moreno‐Espinosa,Valentine Carret,Santiago Pérez-Patrigeón,Daniel E. Noyola,Martín Magaña-Aquino,柏小剑,M. Lourdes Guerrero,John H. Powers,John H. Beigel,Guillermo M. Ruiz‐Palacios	2024	0
3	National Survey of Factors Associated with Physician Antibiotic Prescribing Preferences Journal of General Internal Medicine ·Milindkumar Vaidya,Aaron S. Kesselheim,Robert Morlock,Joshua P. Metlay,John H. Powers,William B. Feldman	2024	0
4	Focusing on antimicrobial resistant infections –are we missing the forest for the trees and the patients for pathogens? SHILAP Revista de lepidopterología ·Alexander Lawandi,Sameer S. Kadri,John H. Powers	2023	1
5	Etiology, clinical characteristics, and risk factors associated with severe influenza-like illnesses in Mexican adults IJID Regions ·MIA BALAH,Ana M. Ortega‐Villa,Ana A. Ortiz‐Hernández,Alejandra Ramírez‐Venegas,Sarbelio Moreno‐Espinosa,Valentine Carret,Santiago Pérez-Patrigeón,Sally Hunsberger,杨磊李燕,Soung Yong Jin,Vega Mercedes,Elizabeth Cantor-Graaeb ve René S. Kahna,Alejandro Casadesús Bordoy,John H. Powers,Guillermo M. Ruiz‐Palacios,John H. Beigel,Arturo Galindo‐Fraga	2023	2
6	Impact of respiratory syncytial virus disease on quality of life in adults aged ≥50 years: A qualitative patient experience cross‐sectional study Influenza and Other Respiratory Viruses ·Desmond Curran,H. H. Silva,謝秀卉,Kimberly Raymond,Nicolet Jean Louis,Е. А. Gaichik,Agus Prastyo Prastyo,John H. Powers	2022	15
7	Comparison of clinical characteristics of Zika and dengue symptomatic infections and other acute illnesses of unidentified origin in Mexico PLoS neglected tropical diseases ·Pablo F. Belaunzarán-Zamudio,Allyson Mateja,MIA BALAH,Héctor Armando Rincón-León,Karla R. Navarro-Fuentes,J. Alexandre,D.F. Zhang,D. J. Buttimer,安田秀男,Gilmar Rodrigues da Rocha,Maia Jambazishvili,Karina del Carmen Trujillo-Murillo,John H. Powers,Sally Hunsberger,Sophia Siddiqui,John H. Beigel,Diane Biddison,Guillermo M. Ruiz‐Palacios	2021	7
8	Antibiotics Approved for Marketing in Populations Specifically Excluded From Premarketing Trials, 1999–2018 Mayo Clinic Proceedings ·S Talkington,John H. Powers,Peter Doshi	2020	3
9	Evidence-Based Study Design for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia The Journal of Infectious Diseases ·George H. Talbot,Anita Das,Stephanie S. Cush,Aaron Dane,Michele Wible,Roger Echols,Antoní Torres,Sue Cammarata,John Rex,John H. Powers,Thomas Fleming,Jeffrey S Loutit,Ye Liang	2018	53
10	Analysis Populations in Anti-Infective Clinical Trials: Whom to Analyze? PubMed ·Scott Evans,Daniel B. Rubin,John H. Powers,Dean Follmann	2018	4
11	Evaluating Anti-infective Drugs in the Resistant Pathogen Setting: Can We Use External Controls? PubMed ·Scott Evans,John H. Powers	2017	1
12	Repairing the Broken Market for Antibiotic Innovation SSRN Electronic Journal ·Kevin Outterson,John H. Powers,Gregory W. Daniel,Mark McClellan	2015	2
13	Development Of A New Patient Reported Outcome (PRO) Measure For Community-Acquired Bacterial Pneumonia (CABP) Value in Health ·Kellee Howard,М.А. Худякова,Ye Liang,Joseph A. Crawley,Dunja Zlatarić,George O Obel,John H. Powers	2014	2
14	Standardizing Measurement of Chronic Obstructive Pulmonary Disease Exacerbations: Reliability and Validity of a Patient-reported Diary American Journal of Respiratory and Critical Care Medicine ·Nancy Kline Leidy,Teresa K. Wilcox,Paul Jones,Laurie Roberts,John H. Powers,Sanjay Sethi	2010	138
15	World Health Organization Ranking of Antimicrobials According to Their Importance in Human Medicine: A Critical Step for Developing Risk Management Strategies for the Use of Antimicrobials in Food Production Animals Clinical Infectious Diseases ·Peter Collignon,John H. Powers,Tom Chiller,Awa Aïdara‐Kane,Frank M. Aarestrup	2009	283
16	Diagnosis and Treatment of Acute Otitis Media: Evaluating the Evidence Infectious Disease Clinics of North America ·John H. Powers	2007	7
17	Civic discourse, civil society, and Chinese communities Randolph Kluver,John H. Powers	1999	38
18	Is life a party for young women Queensland's institutional digital repository (The University of Queensland) ·Wendy J. Brown,Marisela López,John H. Powers	1998	19
19	On the intellectual structure of the human communication discipline Communication Education ·John H. Powers	1995	18
20	PROLONGED SURVIVAL OF ORTHOTOPIC HOMOTRANSPLANTS OF THE HEART IN ANIMALS TREATED WITH METHOTREXATE Journal of Thoracic and Cardiovascular Surgery ·David A. Blumenstock,Herbert B. Hechtman,John A. Collins,Alfred Jaretzki,Jaramillo Costilla,Walter Zingg,John H. Powers	1963	33

About John H. Powers

John H. Powers is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Statistics, Probability and Uncertainty, having authored 136 papers that have together received 5.7k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (26 papers), Health Systems, Economic Evaluations, Quality of Life (21 papers), Antibiotic Resistance in Bacteria (17 papers), Pneumonia and Respiratory Infections (16 papers), Respiratory viral infections research (14 papers), Meta-analysis and systematic reviews (14 papers), Pharmaceutical Economics and Policy (12 papers) and Influenza Virus Research Studies (10 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (922 citations), Molecular Medicine (1.1k citations) and Clinical Biochemistry (534 citations). John H. Powers has collaborated with scholars based in United States, United Kingdom and Mexico. Frequent co-authors include Thomas R. Fleming, Tom Chiller, Brad Spellberg, Eric P. Brass, John E. Edwards, Loren G. Miller, Laurie B. Burke, Donald L. Patrick, Frederick J. Angulo and Jennifer Nelson. Their work appears in journals such as Clinical Infectious Diseases, Value in Health, Open Forum Infectious Diseases, The Lancet Infectious Diseases and JAMA Network Open.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact